AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureHumanitiesInformation ScienceNamed GroupsHealth CareGeographicals
Clinical Trials as TopicCanadaClinical Trials, Phase III as TopicTreatment OutcomeEarly Detection of CancerClinical Trials, Phase II as TopicResearch DesignNeoplasmsClinical Trials, Phase I as TopicBreast NeoplasmsDouble-Blind MethodProspective StudiesFollow-Up StudiesProstatic NeoplasmsLung NeoplasmsControlled Clinical Trials as TopicAntineoplastic AgentsOvarian NeoplasmsUnited StatesSurvival AnalysisPatient SelectionColonic NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsNeoplasm MetastasisStomach NeoplasmsTime FactorsQuestionnairesPrognosisSurvival RateCancer VaccinesRisk FactorsRetrospective StudiesRisk AssessmentDisease ProgressionRandomized Controlled Trials as TopicCombined Modality TherapyMulticenter Studies as TopicNeoplasm InvasivenessPancreatic NeoplasmsOntarioQuality of LifeMice, NudeAge FactorsNational Cancer Institute (U.S.)Drug Administration ScheduleGene Expression Regulation, NeoplasticRiskPlacebosRegistriesDisease-Free SurvivalMedical OncologyDose-Response Relationship, DrugClinical ProtocolsReproducibility of ResultsColorectal NeoplasmsNeoplasm StagingNeoplasm ProteinsDrug Resistance, NeoplasmUterine Cervical NeoplasmsCarcinoma, Non-Small-Cell LungCell Line, TumorGenetic Predisposition to DiseasePilot ProjectsClinical Trials Data Monitoring CommitteesChemotherapy, AdjuvantOdds RatioTumor Markers, BiologicalCarcinomaNeoplasm Recurrence, LocalMultivariate AnalysisClinical Trials, Phase IV as TopicSingle-Blind MethodCarcinoma, Squamous CellXenograft Model Antitumor AssaysSensitivity and SpecificityMutationKaplan-Meier EstimateSmokingCost-Benefit AnalysisUrinary Bladder NeoplasmsReverse Transcriptase Polymerase Chain ReactionLogistic ModelsDrug Therapy, CombinationFluorouracilIncidencePredictive Value of TestsAntibodies, MonoclonalEvidence-Based MedicineReceptors, EstrogenGene Expression ProfilingEarly Termination of Clinical TrialsReceptor, erbB-2SurvivorsOutcome Assessment (Health Care)AlbertaMolecular Targeted TherapyCisplatinRectal NeoplasmsPractice Guidelines as TopicSeverity of Illness Index